Recent Financing
Recent Raise
Windward Bio is a clinical-stage biotechnology company developing long-acting monoclonal and bispecific antibody therapies for serious immunological diseases.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Windward Bio.
